Javascript must be enabled to continue!
Anticonvulsant‐induced lymphoma
View through CrossRef
AbstractPatients with cervical adenopathy of obscure etiology may present a diagnostic problem to the otolaryngologist. The hydantoin family of anticonvulsants is a rare cause of adenopathy that may range from histologically simple lymphoid hyperplasia to true lymphoma. Between these two extremes is a benign clinical entity with the histologic characteristics of lymphoma.A patient on diphenylhydantoin (Dilantin) therapy developed bilateral true vocal cord paralysis and cervical adenopathy. On pathological examination the lesion was interpreted first as malignant lymphoma and later as hydantoin‐induced pseudolymphoma. He has now been followed for over two years.Hydantoin‐induced adenopathy may vary clinically from a benign condition to a true lymphoma. The malignant form may present long after the anticonvulsant treatment is discontinued. A 10‐fold increase in the expected incidence of malignant lymphoma in epileptic patients on hydantoin therapy has been reported; therefore, these patients required long‐term follow‐up.The otolaryngologist should be aware of this rare clinical entity as an unusual cause of cervical adenopathy associated with vocal cord paralysis.
Title: Anticonvulsant‐induced lymphoma
Description:
AbstractPatients with cervical adenopathy of obscure etiology may present a diagnostic problem to the otolaryngologist.
The hydantoin family of anticonvulsants is a rare cause of adenopathy that may range from histologically simple lymphoid hyperplasia to true lymphoma.
Between these two extremes is a benign clinical entity with the histologic characteristics of lymphoma.
A patient on diphenylhydantoin (Dilantin) therapy developed bilateral true vocal cord paralysis and cervical adenopathy.
On pathological examination the lesion was interpreted first as malignant lymphoma and later as hydantoin‐induced pseudolymphoma.
He has now been followed for over two years.
Hydantoin‐induced adenopathy may vary clinically from a benign condition to a true lymphoma.
The malignant form may present long after the anticonvulsant treatment is discontinued.
A 10‐fold increase in the expected incidence of malignant lymphoma in epileptic patients on hydantoin therapy has been reported; therefore, these patients required long‐term follow‐up.
The otolaryngologist should be aware of this rare clinical entity as an unusual cause of cervical adenopathy associated with vocal cord paralysis.
Related Results
Exploring the Association between Lymphoma and Inflammatory Bowel Disease in an Inner-City Academic Institution
Exploring the Association between Lymphoma and Inflammatory Bowel Disease in an Inner-City Academic Institution
Introduction:
The incidence of lymphoma has been increasing over the past several decades, with data showing an estimated annual percentage change of 0.56%. There...
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Abstract
Introduction
Non-Hodgkin lymphoma (NHL) of the thyroid, a rare malignancy linked to autoimmune disorders, is poorly understood in terms of its pathogenesis and treatment o...
The Analysis of HIV-Associated Lymphoma in Japan
The Analysis of HIV-Associated Lymphoma in Japan
Abstract
Background.
The recent advance of antiretroviral therapy decreased the morbidity of opportunistic infections. However, the incidence of HIV-a...
Beneficios de la quimioterapia adyuvante en los resultados de supervivencia del cáncer de mama triple negativo pT1N0M0
Beneficios de la quimioterapia adyuvante en los resultados de supervivencia del cáncer de mama triple negativo pT1N0M0
Introduction Collaborative health research has proven to be an effective approach to addressing regional and international challenges in the diagnosis, treatment, and management o...
Comparison of FDG-PET and Ga-67 Scintigraphy in the Evaluation of Lymphoma and Its Relationship to the Pathologic Diagnosis Using WHO Classification System.
Comparison of FDG-PET and Ga-67 Scintigraphy in the Evaluation of Lymphoma and Its Relationship to the Pathologic Diagnosis Using WHO Classification System.
Abstract
In the management of lymphoma patients, 18fluoro-2-deoxyglucose positron emission tomography (FDG-PET) has emerged as an important tool. However there are c...
Endoscopic and Histopathological Characteristics of Gastrointestinal Lymphoma: A Multicentric Study
Endoscopic and Histopathological Characteristics of Gastrointestinal Lymphoma: A Multicentric Study
Background: Extranodal non-Hodgkin lymphoma (NHL) is more prevalent in the gastrointestinal (GI) tract than in other sites. This study aimed to determine the endoscopic characteris...

